Creating a technology-based HIV prevention program for Black women with substance use issues
Development of a Technology-Based HIV Prevention Intervention for Black Women Who Use Substances
This study is creating a helpful program using technology to support Black women in treatment for substance use disorders, aiming to prevent HIV by addressing their unique challenges and making resources more accessible.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11021039 on NIH RePORTER |
What this research studies
This research aims to develop a technology-based intervention specifically designed to prevent HIV among Black women undergoing treatment for substance use disorders. The program will build on a previously successful culturally-adapted intervention and will incorporate modern prevention strategies while considering the unique challenges faced by this population. By utilizing technology, the intervention seeks to reach women who may not have access to in-person support due to stigma or limited availability of services. The approach is informed by the intersection of various social factors that contribute to increased HIV risk in this demographic.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black women who are currently in treatment for substance use disorders and are at risk for HIV.
Not a fit: Patients who do not identify as Black women or who are not undergoing treatment for substance use disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of HIV among Black women with substance use disorders.
How similar studies have performed: Previous research has shown that technology-based interventions can be effective in both substance use treatment and HIV prevention among Black women, indicating a promising approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Mccuistian, Caravella — University of California, San Francisco
- Study coordinator: Mccuistian, Caravella
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.